688193 仁度生物
按盤價 
48.300 +0.220 (+0.458%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.766 | -0.833 | 0.858 | 3.736 | 25.705 |
| 總資產報酬率 ROA (%) | 0.707 | -0.763 | 0.771 | 3.180 | 18.747 |
| 投入資產回報率 ROIC (%) | 0.757 | -0.822 | 0.844 | 3.639 | 24.148 | 邊際利潤分析 |
| 銷售毛利率 (%) | 77.750 | 79.487 | 81.256 | 65.529 | 74.623 |
| 營業利潤率 (%) | 6.317 | -8.224 | 3.310 | 9.053 | 24.696 |
| 息稅前利潤/營業總收入 (%) | 5.278 | -12.093 | -2.053 | 7.333 | 24.277 |
| 淨利潤/營業總收入 (%) | 5.886 | -4.405 | 5.024 | 7.679 | 22.107 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -169.568 | 80.414 | -375.331 | 50.140 | 90.092 |
| 價值變動淨收益/利潤總額(%) | 145.485 | -71.851 | 159.276 | 34.935 | 1.676 |
| 營業外收支淨額/利潤總額(%) | -2.523 | 4.182 | -14.271 | -3.094 | 0.350 | 償債能力分析 |
| 流動比率 (X) | 13.878 | 11.889 | 11.462 | 10.188 | 4.261 |
| 速動比率 (X) | 13.503 | 11.552 | 11.097 | 9.892 | 3.969 |
| 資產負債率 (%) | 7.253 | 8.295 | 8.720 | 11.696 | 23.999 |
| 帶息債務/全部投入資本 (%) | 0.081 | 0.562 | -0.095 | -1.251 | -3.687 |
| 股東權益/帶息債務 (%) | 121,649.423 | 17,544.316 | -104,367.986 | -7,834.932 | -2,590.861 |
| 股東權益/負債合計 (%) | 1,278.685 | 1,105.590 | 1,046.754 | 754.992 | 316.691 |
| 利息保障倍數 (X) | -5.969 | 3.445 | 0.415 | -5.064 | -48.026 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 109.281 | 128.061 | 198.893 | 94.892 | 58.176 |
| 存貨周轉天數 (天) | 250.627 | 265.854 | 332.262 | 81.934 | 86.706 |
| 備註： | 即時報價更新時間為 30/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
